Congratulations to all winners of the KCA Annual Meeting 2023 Best Poster Award.

1. Na Hyun Gwon

The effectiveness of intervention timing on cancer related fake news: Lessons from the fenbendazole scandal

2. Tung Hoang

Genetically predicted dietary intake and risks of colorectal cancer: a Mendelian randomization study

3. Yuan-Yu Hsia

Exploration of metabolic and molecular regulators in Cisplatin resistant oral cancers

4. Chun Yu Hsieh

Impact of tissue inhibitor of metalloproteinase-3 genetics polymorphisms on biochemical recurrence and clinicopathological characteristics in Taiwanese patients with prostate cancer

5. Sara Jeon

Newly subtyping and targeting triple negative breast cancer (TNBC) based on DeltaNp63α expression of TNBC patient-derived organoid

6. Yaofei Jiang

Single-cell transcriptome analysis reveals therapy-induced evolution of tumor microenvironment in nasopharyngeal carcinoma

7. Worasak Kaewkong

A splicing factor protein kinase inhibitor, SRPIN340 exhibits anti-growth effect via the induction of apoptotic/autophagic-death and limiting metastatic ability of glioma cell.

8. Yeon-koo Kang

Preoperative assessment of N2 mediastinal lymph nodes in non-small cell lung cancer using Ga-68 FAPI PET/CT: A prospective pilot study

9. Dokyeong Kim

Establishment of patient-derived brain tumor organoids with tumor microenvironment - application to drug screening

10. Dowook Kim

Optimizing salvage treatment for recurrent glioblastoma: A multicenter study integrating genetic biomarkers from the Korean Radiation Oncology Group (KROG 21-02)

11. Kyoo Hyun Kim

A phase II trial of nintedanib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC): In-depth analysis of nintendanib arm from the KCSG HN 15-16 TRIUMPH trial

12. Sheehyun Kim

Mutational evolution after chemotherapy-progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis

13. Tae Hoon Kim

Targeting GAS6 improves the response to immunotherapy by generating the immunogenic tumor microenvironment in gastric cancer

14. Soyeon Ko

DDR1 targeting enhances the anticancer effect of gemcitabine by ECM remodeling in pancreatic cancer

15. Yujin Kwon

Identification of novel pathogenic roles of BLZF1/ATF6 in tumorigenesis of gastrointestinal stromal tumor showing Golgi-localized mutant KIT

16. Hye In Lee

Relationships between microbiome and response to neoadjuvant chemoradiotherapy in rectal cancer

17. Sunju Lee

Kaposi sarcoma herpes virus exploits the lymphatic cell environment to enhance productive lytic replication through prox1 activation

18. Sathya Veera Merla

Splenic B-cell lymphoma / leukemia with prominent nucleoli

19. Jian Oh

Association of particulate matter and the risk of atherosclerotic cardiovascular disease among 5-year cancer survivors

20. Maiyon Park

Chmp1A inhibits cancer growth by interaction with Septin proteins to suppress their oncogenic activity in pancreatic cancer

21. Cyril Jonas Planilla

Knowledge, attitudes, and practices related to COVID-19 among cancer patients seen at the outpatient clinics of a tertiary cancer care center: A Cross-sectional study

22. Narankhuu Ragchaasuren

Antitumor effects of traditional Mongolian herbal medicine on gastric adenocarcinoma

23. Kyeong Jin Shin

NSMF promotes colorectal cancer development and progression through regulation of replication stress response

24. Thoudam Debraj Singh

Estrogen-related receptor (ERRγ) as a potential biomarker and therapeutic target for anaplastic and papillary thyroid cancer and the synergetic anti-tumor effect of DN200434 (a potent inverse agonist of ERRγ) and MK2206 (Akt inhibitor) in Thyroid cancer cells

25. Pattaralawan Sittiju

Bacteriophage-based particle carrying TRAIL gene for targeted cancer therapy in osteosarcoma

26. Jason King Talao

Clinical profiles and outcomes of patients enrolled in the Department of Health - Breast Cancer Medicines Access Program: A single center experience

27. Richmarie Grace Uy

Dosimetric comparison of 3D printed boluses with varying infills and different clinically used bolus materials

28. Byeongmin Yu

Hippo pathway dysregulation on Helicobacter pylori-related gastric cancer

29. Yebeen Yu

Ovarian cancer patient-derived organoids recapitulate the clinical response of the patient